Novartis Institutes for Biomedical Research Business Analyst Salaries in Corvallis, OR
The average Novartis Institutes for Biomedical Research Business Analyst in Corvallis, OR earns an estimated $92,712 annually, which includes an estimated base salary of $84,712 with a $8,000 bonus. Novartis Institutes for Biomedical Research's Business Analyst compensation is $9,241 more than the US average for a Business Analyst.
In Corvallis, OR, The Marketing Department at Novartis Institutes for Biomedical Research earns $1,030 more on average than the Business Development Department.
Last updated 3 years ago.
- $84,712
- avg. base
- $8,000
- avg. bonus
Business Analyst Salaries at Novartis Institutes for Biomedical Research
In Corvallis, OR, Business Analysts earn $46 more than Business Analysts, and $10,500 less than Marketing Managers.
Compensation at Novartis Institutes for Biomedical Research by Department
In Corvallis, OR, The Marketing Department averages $1,030 more than the Business Development Department, and $13,384 less than the Product Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $85,427, while the average male Business Analyst at similar sized companies reported making $93,384.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $97,000, while the average African American/Black Business Analyst at similar sized companies reported making $76,443.
How Business Analysts at Novartis Institutes for Biomedical Research Rate Their Compensation
The majority of Business Analysts at Novartis Institutes for Biomedical Research believe they're compensated fairly. 100% of Business Analysts at Novartis Institutes for Biomedical Research say they receive annual bonuses, and the majority (43%) are not satisfied with their benefits. See more compensation ratings at Novartis Institutes for Biomedical Research
